- Design
- Prospective interventional diagnostic study
- Population
- 39 patients, 42 non-melanoma skin cancers, 261 Mohs margins
- Primary outcome
- Agreement with histopathology and between readers
- Effect
- Accuracy 96.4%; inter-reader kappa 0.86 for margins
A prospective Italian study examined 261 margins from 42 non-melanoma skin cancers in 39 patients having Mohs surgery, using ex vivo fluorescence confocal microscopy in a digital stain mode that produces haematoxylin-and-eosin-like images. A dermatologist and a pathologist read each margin independently and blind.
Agreement between the two readers was almost perfect for margins (kappa 0.86, 98.6% observed agreement) and tumour type (kappa 0.88). Against conventional histopathology, overall accuracy was 96.4%, with one false-negative margin and one discordance from sample processing.
Confocal imaging avoids frozen-section preparation and could shorten Mohs turnaround. The single false negative is a reminder that it is not yet a replacement for histology in every setting.
The study did not measure time savings, and the equipment is costly and not widely available in India.
- Confocal imaging produced images that trained readers interpreted reliably.
- Readers needed specific training; agreement relied on it.
- One margin was falsely called clear; keep histological confirmation where pathways require it.
- Workflow gains have not yet been measured.
Why it matters
It points to a margin check that skips the cryostat.
The statistics, in plain English
Kappa above 0.8 is conventionally called almost perfect agreement. An accuracy of 96.4% across 261 margins still left one positive margin missed.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for pathology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free